• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乌帕替尼联合窄谱中波紫外线治疗儿童难治性节段性白癜风和斑秃:一例报告

Treatment of Refractory Segmental Vitiligo and Alopecia Areata in a Child with Upadacitinib and NB-UVB: A Case Report.

作者信息

Mu Yuzhu, Pan Ting, Chen Lingling

机构信息

Department of Dermatology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, Jiangsu, 215000, People's Republic of China.

出版信息

Clin Cosmet Investig Dermatol. 2024 Aug 6;17:1789-1792. doi: 10.2147/CCID.S467026. eCollection 2024.

DOI:10.2147/CCID.S467026
PMID:39132025
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11316469/
Abstract

Vitiligo and alopecia areata are both autoimmune skin diseases, and the chances of co-occurrence are very low. Conventional treatments often include glucocorticoids, which have many adverse reactions with long-term use and are difficult to achieve satisfactory results. Upadacitinib has been found to be effective in both vitiligo and alopecia areata due to partial overlap in pathogenic pathways. We report the successful treatment of vitiligo combined with alopecia areata in a nine-year-old child with upadacitinib in combination with UVB. The area of vitiligo and alopecia areata decreased significantly, and satisfactory results were obtained. It provides a new idea for the treatment of vitiligo complicated with alopecia areata in children.

摘要

白癜风和斑秃均为自身免疫性皮肤病,二者同时出现的几率很低。传统治疗方法通常包括使用糖皮质激素,长期使用会产生诸多不良反应,且难以取得满意疗效。由于致病途径存在部分重叠,已发现乌帕替尼对白癜风和斑秃均有效。我们报告了一名9岁儿童使用乌帕替尼联合紫外线B成功治疗白癜风合并斑秃的病例。白癜风和斑秃的面积显著减小,取得了满意的效果。这为儿童白癜风合并斑秃的治疗提供了新思路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1902/11316469/ebcb6b8d48f6/CCID-17-1789-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1902/11316469/0b9d40c08557/CCID-17-1789-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1902/11316469/ebcb6b8d48f6/CCID-17-1789-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1902/11316469/0b9d40c08557/CCID-17-1789-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1902/11316469/ebcb6b8d48f6/CCID-17-1789-g0002.jpg

相似文献

1
Treatment of Refractory Segmental Vitiligo and Alopecia Areata in a Child with Upadacitinib and NB-UVB: A Case Report.乌帕替尼联合窄谱中波紫外线治疗儿童难治性节段性白癜风和斑秃:一例报告
Clin Cosmet Investig Dermatol. 2024 Aug 6;17:1789-1792. doi: 10.2147/CCID.S467026. eCollection 2024.
2
Successful treatment of concomitant alopecia universalis and Crohn's disease with upadacitinib: A case report.乌帕替尼成功治疗泛发性斑秃合并克罗恩病:一例报告
SAGE Open Med Case Rep. 2023 Mar 21;11:2050313X231160914. doi: 10.1177/2050313X231160914. eCollection 2023.
3
Colocalization of vitiligo and alopecia areata presenting as poliosis.白癜风与斑秃伴白发的共定位。
J Cutan Pathol. 2015 Feb;42(2):150-4. doi: 10.1111/cup.12437. Epub 2014 Dec 23.
4
Case report: Psoriasiform eczema with immune-mediated comorbidities treated with upadacitinib.病例报告:用乌帕替尼治疗伴有免疫介导合并症的类银屑病样湿疹。
Front Immunol. 2024 Aug 5;15:1432233. doi: 10.3389/fimmu.2024.1432233. eCollection 2024.
5
Drug-Induced Alopecia Areata From Upadacitinib.乌帕替尼所致药物性斑秃
Cureus. 2024 Aug 11;16(8):e66647. doi: 10.7759/cureus.66647. eCollection 2024 Aug.
6
Vitiligo and alopecia areata: apples and oranges?白癜风和斑秃:苹果和橙子?
Exp Dermatol. 2013 Dec;22(12):785-9. doi: 10.1111/exd.12264.
7
Upadacitinib for Alopecia Areata in Different Backgrounds: A Case Series.乌帕替尼用于不同背景下斑秃的病例系列研究
Clin Cosmet Investig Dermatol. 2024 Mar 9;17:565-571. doi: 10.2147/CCID.S458592. eCollection 2024.
8
Macrophage Migration Inhibitory Factor in Alopecia Areata and Vitiligo: A Case-Controlled Serological Study.斑秃和白癜风中巨噬细胞移动抑制因子:一项病例对照血清学研究
J Clin Aesthet Dermatol. 2020 Oct;13(10):24-27. Epub 2020 Oct 1.
9
Understanding autoimmunity of vitiligo and alopecia areata.了解白癜风和斑秃的自身免疫性。
Curr Opin Pediatr. 2016 Aug;28(4):463-9. doi: 10.1097/MOP.0000000000000375.
10
Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata.关于靶向JAK/STAT通路药物在特应性皮炎、白癜风和斑秃中应用的范围综述
Dermatol Ther (Heidelb). 2019 Dec;9(4):655-683. doi: 10.1007/s13555-019-00329-y. Epub 2019 Oct 13.

引用本文的文献

1
Upadacitinib Therapy in Adolescent Severe Alopecia Areata: A Case Series and Narrative Review.乌帕替尼治疗青少年重度斑秃:病例系列与叙述性综述
Clin Cosmet Investig Dermatol. 2025 Sep 3;18:2141-2148. doi: 10.2147/CCID.S549823. eCollection 2025.

本文引用的文献

1
Alopecia Areata: Current Treatments and New Directions.斑秃:现有治疗方法和新方向。
Am J Clin Dermatol. 2023 Nov;24(6):895-912. doi: 10.1007/s40257-023-00808-1. Epub 2023 Aug 22.
2
Efficacy and tolerability of oral upadacitinib monotherapy in patients with recalcitrant vitiligo.口服乌帕替尼单药治疗顽固性白癜风患者的疗效和耐受性。
J Am Acad Dermatol. 2023 Dec;89(6):1257-1259. doi: 10.1016/j.jaad.2023.07.1016. Epub 2023 Jul 28.
3
Treatment of alopecia areata with the janus kinase inhibitor upadacitinib: A retrospective cohort study.
使用JAK激酶抑制剂乌帕替尼治疗斑秃:一项回顾性队列研究。
J Am Acad Dermatol. 2023 Jul;89(1):137-138. doi: 10.1016/j.jaad.2022.12.056. Epub 2023 Feb 15.
4
Vitiligo Treatments: Review of Current Therapeutic Modalities and JAK Inhibitors.白癜风治疗:当前治疗方式及JAK抑制剂综述
Am J Clin Dermatol. 2023 Mar;24(2):165-186. doi: 10.1007/s40257-022-00752-6. Epub 2023 Jan 30.
5
Comorbidities in Patients with Vitiligo: A Systematic Review and Meta-Analysis.白癜风患者的合并症:一项系统评价和荟萃分析。
J Invest Dermatol. 2023 May;143(5):777-789.e6. doi: 10.1016/j.jid.2022.10.021. Epub 2022 Nov 28.
6
Immunometabolism in the pathogenesis of vitiligo.免疫代谢在白癜风发病机制中的作用。
Front Immunol. 2022 Nov 10;13:1055958. doi: 10.3389/fimmu.2022.1055958. eCollection 2022.
7
Assessment of alopecia areata universalis successfully treated with upadacitinib.用乌帕替尼成功治疗泛发性斑秃的评估。
Int J Dermatol. 2023 Feb;62(2):e61-e63. doi: 10.1111/ijd.16342. Epub 2022 Jul 2.
8
Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials.每日一次乌帕替尼对比安慰剂治疗中重度特应性皮炎青少年和成人患者(Measure Up1 和 Measure Up2):两项复制性、双盲、随机对照 3 期临床试验结果。
Lancet. 2021 Jun 5;397(10290):2151-2168. doi: 10.1016/S0140-6736(21)00588-2. Epub 2021 May 21.